Jackson Acquisition CO Ii 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

NYSE
Jackson Acquisition Company II reports Q3 2025 net income driven by trust account interest, as it continues its search for a healthcare business combination target ahead of its December 2026 deadline.
NYSE
Jackson Acquisition Company II, a SPAC targeting healthcare, reported a net income of $2.3 million for Q2 2025, primarily from interest on its $237.7 million trust account.
NYSE
Jackson Acquisition Company II, a blank check company, reported a net income of $2.2 million for the quarter ended March 31, 2025, primarily driven by interest earned on marketable securities held in trust.
NYSE
Jackson Acquisition Company II, a healthcare-focused SPAC, files its first quarterly report since its inception and recent IPO, detailing formation activities and initial financial position.